FOXP3 and cancer: In addition, we aimed to clarify part of the immune responses in localized areas of virus‐infected cancers by determining the survival prognoses in patients with OSCC with and without HPV infection and the associations between the presence of FoxP3+ Tregs and clinicopathological indicators in HPV‐positive OSCC that have not yet been reported.